Home/Filings/4/0001104659-20-007120
4//SEC Filing

Perros Manoussos 4

Accession 0001104659-20-007120

CIK 0001724344other

Filed

Jan 26, 7:00 PM ET

Accepted

Jan 27, 4:06 PM ET

Size

5.5 KB

Accession

0001104659-20-007120

Insider Transaction Report

Form 4
Period: 2020-01-23
Perros Manoussos
DirectorPresident and CEO
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-01-23+145,000145,000 total
    Exercise: $4.94Exp: 2030-01-22Common Stock (145,000 underlying)
Footnotes (1)
  • [F1]Twenty-five percent (25%) of the shares subject to the option shall vest on January 1, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Documents

1 file

Issuer

Entasis Therapeutics Holdings Inc.

CIK 0001724344

Entity typeother

Related Parties

1
  • filerCIK 0001751832

Filing Metadata

Form type
4
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 4:06 PM ET
Size
5.5 KB